PainTEQ Revenue and Competitors

Orlando, FL USA

Location

#2101

Growjo Ranking

Estimated Revenue & Valuation

  • PainTEQ's estimated annual revenue is currently $41.7M per year.(i)
  • PainTEQ's estimated revenue per employee is $404,524

Employee Data

  • PainTEQ has 103 Employees.(i)
  • PainTEQ grew their employee count by -23% last year.

PainTEQ's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
EVPReveal Email/Phone
4
SVP, Reimbursement & Market AccessReveal Email/Phone
5
Regional Area DirectorReveal Email/Phone
6
Director Quality and R&DReveal Email/Phone
7
Chief Commercial OfficerReveal Email/Phone
8
Director Clinical Education and TrainingReveal Email/Phone
9
Director MarketingReveal Email/Phone
10
Area Sales DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.1M1040%$63.5MN/A
#2
$14.3M5415%N/AN/A
#3
$33.1M1178%N/AN/A
#4
$10.8M4631%N/AN/A
#5
$488.3M12160%N/AN/A
#6
$14.3M44-6%N/AN/A
#7
$5M20-9%N/AN/A
#8
$95.6M306-2%N/AN/A
#9
$16.8M609%N/AN/A
#10
$57M27522%N/AN/A
Add Company

What Is PainTEQ?

PainTEQ provides solutions and services to the interventional pain management community. PainTEQ's goal is to provide the interventional spine specialist with procedures that are FDA approved and safe while also being clinically proven as effective care options.

keywords:N/A

N/A

Total Funding

103

Number of Employees

$41.7M

Revenue (est)

-23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PainTEQ News

2022-03-30 - Tampa-Based Medical Device Company, PainTEQ, Treats ...

About PainTEQ: Built to bring interventional procedures to the market, PainTEQ is a medical device innovator headquartered in Tampa, Florida.

2022-03-22 - PainTEQ Appoints Two New Vice Presidents

Dedicated to bringing interventional procedures to the market, PainTEQ is focused on delivering its minimally-invasive LinQ system to as many...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.7M103-1%N/A
#2
$12.8M103-2%N/A
#3
$30.2M1040%N/A
#4
$28.6M104-12%N/A
#5
$9M10460%N/A